Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
January 2026: MHRA approves Wegovy 7.2mg higher dose narrowing the efficacy gap with Mounjaro to ~1.8 percentage points
Beyond Diabetes and Obesity: Researchers are studying numerous additional indications that could expand the use of these medications beyond diabetes and obesity
If we find only mild retinopathy progression or minimal fluid accumulation without vision loss, we may recommend close monitoring rather than treatment
This potent antioxidant acts as the defense line to fight against free radicals and other DNA-affecting compounds present in pollutants, overexposure to sun rays, and smoking habits
A new drug for the treatment of intermittent claudication
BPC-157 demonstrates remarkable stability across pH ranges, remaining active in both acidic gastric environments and neutral tissue conditions
